Being diagnosed with multiple sclerosis (MS) is a life sentence, as the disease can seriously affect a sufferer's motor skills and cognitive abilities, but new hope might be on the way. This week, the US Food and Drug Administration (FDA) has approved a new drug, called ocrelizumab, which fights MS by targeting the body's B cells and is the first to have an effect on the more severe form of the disease.
.. Continue Reading FDA approves first drug to fight severe forms of MSCategory: Medical
Tags: Related Articles:
- Rebooting the immune system fights off early MS
- First blood biomarker for multiple sclerosis discovered
- MS-afflicted volleyball player designs award-winning Sports Walker
- Drug-like molecule halts inflammation, could prevent progression of MS
- Existing skin medications may reverse effects of multiple sclerosis
- New drug promises to reverse the progression of Multiple Sclerosis
from New Atlas http://ift.tt/2oaCN2k
No comments:
Post a Comment